Select publications

D’Amico AV et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280(11):969-74. Abstract

Gleave M et al. Randomized comparative study of 3 vs 8 months of neoadjuvant hormonal therapy prior to radical prostatectomy: 3 year psa recurrence rates. Proc AUA 2003;Abstract 690.

Kattan MW et al. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999;17(5):1499-507. Abstract

Klotz L et al. Neoadjuvant hormone therapy: The Canadian trials. Mol Urol 2000;4(3):233-7. Abstract

Peto R, Dalesio O. Breast and prostate cancer: 10-year survival gains in the hormonal adjuvant treatment trials. European Journal of Cancer Supplements 2003;1(5):S101;Abstract 328.

Soloway MS et al. Neoadjuvant androgen ablation before radical prostatectomy in cT2bNxMo prostate cancer: 5-year results. J Urol 2002;167(1):112-6. Abstract